Optimal Medical Therapy
Optimal Medical Therapy is a pharmaceutical drug with 28 clinical trials. Currently 7 active trials ongoing. Historical success rate of 57.1%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
53.3%
8 of 15 finished
46.7%
7 ended early
7
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
TRISCEND II Pivotal Trial
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
Clinical Trials (28)
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
TRISCEND II Pivotal Trial
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
A Randomized Controlled Trial of InterVapor® in France - The TARGET Trial
Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
The British Heart Foundation SENIOR-RITA Trial
TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.
Edge-to-edge Mitral Valve Repair in ATTR-CM
COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina
Electrophysiological Effects of Late PCI After MI
EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)
Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study
Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure
Randomized Comparison of Optimal Medical Therapy and Percutaneous Recanalization for Chronic Total Occlusion (COMET-CTO)
Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 28